Build High-Impact KOL Relationships That Drive Results
Without strategic KOL engagement, even promising therapies risk slow market penetration and missed opportunities. This playbook provides a proven four-step framework to help medical affairs teams optimize KOL programs for maximum clinical impact.
What you'll learn:
Complete the form to immediately receive the playbook and transform KOL engagement from a tactical activity into a competitive advantage!
About the author: Priyanka Patel, PharmD, is Managing Director of Medical at BGB Group, with extensive medical affairs expertise spanning 20+ therapeutic areas including oncology and diabetes.
Without strategic KOL engagement, even promising therapies risk slow market penetration and missed opportunities. This playbook provides a proven four-step framework to help medical affairs teams optimize KOL programs for maximum clinical impact.
What you'll learn:
- Strategic identification and prioritization methods
- Objective alignment and engagement strategies
- Performance measurement best practices
- Sustainable partnership development tactics
Complete the form to immediately receive the playbook and transform KOL engagement from a tactical activity into a competitive advantage!
About the author: Priyanka Patel, PharmD, is Managing Director of Medical at BGB Group, with extensive medical affairs expertise spanning 20+ therapeutic areas including oncology and diabetes.
Want to connect with a BGB Group medical affairs expert today?
Email Amanda Eckel, SVP, Client Partnership & Innovation
Copyright © 2025 BGB Group. All rights reserved.